Android app on Google Play

Aegis Capital Upgrades Sinovac Biotech (SVA) to Buy

August 15, 2013 9:04 AM EDT Send to a Friend
Get Alerts SVA Hot Sheet
Price: $5.04 +1.41%

Rating Summary:
    4 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 14 | New: 38
Trade SVA Now!
Join SI Premium – FREE
Aegis Capital upgraded Sinovac Biotech (NASDAQ: SVA) from Hold to Buy with a price target of $7.00.

For an analyst ratings summary and ratings history on Sinovac Biotech click here. For more ratings news on Sinovac Biotech click here.

Shares of Sinovac Biotech closed at $4.57 yesterday.

You May Also Be Interested In

Related Categories


Add Your Comment